Navigation Links
New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence
Date:10/23/2008

Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at http://www.masimo.com.

Forward Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our belief that the applications of Masimo Rainbow SET technologies described in the foregoing clinical studies will deliver a sufficient level of clinical improvement over alternative measurement capabilities to allow for rapid adoption of the technology, and risks related to our assumptions regarding the repeatability of clinical results at other hospitals and healthcare settings, and risks related to our assumptions regarding timing or commercial availability of SpHb, as well as other factors discussed in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the fiscal quarter ended June 28, 2008, filed with the Securi
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...Oct. 29 Ventaira Pharmaceuticals,announced today ...t leader,will acquire Ventaira,s assets and assist...ms of the acquisition were not disclosed. "We wil...s. In,addition, we will work closely with Battelle...yees," said Leslie Williams, President and CEO,of ...
..., Oct. 29 TorreyPines Therapeutics,Inc. (Nasdaq: ...dent and,Chief Executive Officer of TorreyPines, w...9th Annual Healthcare Conference in New York on Mo...t of Dr. Kurtz,s presentation will be available li...reypinestherapeutics.com . An archived version,of ...
..., Oct. 29 Immunosyn,Corporation (OTC Bulletin Boa...d Criner as the company,s Chief Financial and Acco... and Accounting Officer, Douglas A.,McCain, Jr., h... Board and,further retains his position as Corpora...logy and its resulting,biopharmaceutical product c...
Other Biology Technology:Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle 2Immunosyn Corporation Names G. David Criner as CFO 2
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 1Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 2Neuropathic pain 3A The sea provides a new hope of relief 9475 1Neuropathic pain 3A The sea provides a new hope of relief 9475 2Demi Lovato Joins National Bullying Prevention Movement 53681 1Demi Lovato Joins National Bullying Prevention Movement 53681 2
...maceuticals, Inc. today announced that it has been...vation Research Grant (SBIR) from the National Ins... Institutes of Health (NIH) to develop in vivo zeb...rome (CYP) P450s. CYP profiling, a critical step ...rug Administration (FDA) for all new drug approval...
...the University of Florida, has donated $250,000 to...e establishment of an endowment to award creative ... find alternative solutions to problems that signi...t from the $250,000 will be presented to the winne...Innovation and Creativity in Entomology. , "I wan...
...is. Pop culture heedlessly and wrongly lumps th... paleontologists assumed that because the creature...sing only two legs to take flight. , Now comes...aunching some 500 pounds of reptilian heft into fl...re ultra-strong wings which, when folded and balan...
Other Biology News:NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays 2Florida professor creates endowment for insect scientists 2Four, three, two, one . . . pterosaurs have lift off 2
Mouse Anti-hnRNP F / H Monoclonal Antibody, Unconjugated, Clone 1G11 from Novus Biologicals
Rabbit Anti-Human Reptin / TIP49B / RUVB2 Polyclonal Antibody, Unconjugated from Abcam
Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: